Oct 18, 2017
With an FDA decision for ibalizumab pending, data about a group with multidrug resistance show that the antibody is effective.
seen from Germany
seen from China
seen from Singapore
seen from United States
seen from Iraq
seen from Ukraine
seen from United Kingdom
seen from Serbia
seen from United States
seen from Yemen
seen from Guatemala
seen from Japan
seen from United States
seen from Malaysia
seen from China
seen from United States
seen from United States
seen from Chile
seen from United States
seen from United States
With an FDA decision for ibalizumab pending, data about a group with multidrug resistance show that the antibody is effective.
Revenues Up For Theratechnologies ! http://newish.info/69111-revenues-up-for-theratechnologies